Hostname: page-component-89b8bd64d-5bvrz Total loading time: 0 Render date: 2026-05-08T15:33:45.587Z Has data issue: false hasContentIssue false

Effects of dietary plant meal and soya-saponin supplementation on intestinal and hepatic lipid droplet accumulation and lipoprotein and sterol metabolism in Atlantic salmon (Salmo salar L.)

Published online by Cambridge University Press:  05 September 2013

Min Gu*
Affiliation:
Department of Basic Science and Aquatic Medicine, Norwegian School of Veterinary Science, Aquaculture Protein Centre (a CoE), PO Box 8146 Dep, NO-0033 Oslo, Norway The Key Laboratory of Mariculture (Ministry of Education), Ocean University of China, 5 Yushan Road, Qingdao, Shandong 266003, People's Republic of China
Trond M. Kortner
Affiliation:
Department of Basic Science and Aquatic Medicine, Norwegian School of Veterinary Science, Aquaculture Protein Centre (a CoE), PO Box 8146 Dep, NO-0033 Oslo, Norway
Michael Penn
Affiliation:
Department of Basic Science and Aquatic Medicine, Norwegian School of Veterinary Science, Aquaculture Protein Centre (a CoE), PO Box 8146 Dep, NO-0033 Oslo, Norway
Anne Kristine Hansen
Affiliation:
Nofima AS, NO-6600 Sunndalsøra, Norway
Åshild Krogdahl
Affiliation:
Department of Basic Science and Aquatic Medicine, Norwegian School of Veterinary Science, Aquaculture Protein Centre (a CoE), PO Box 8146 Dep, NO-0033 Oslo, Norway
*
* Corresponding author: M. Gu, fax +86 532 82032145, email gumin.ouc@gmail.com
Rights & Permissions [Opens in a new window]

Abstract

Altered lipid metabolism has been shown in fish fed plant protein sources. The present study aimed to gain further insights into how intestinal and hepatic lipid absorption and metabolism are modulated by plant meal (PM) and soya-saponin (SA) inclusion in salmon feed. Post-smolt Atlantic salmon were fed for 10 weeks one of four diets based on fishmeal or PM, with or without 10 g/kg SA. PM inclusion resulted in decreased growth performance, excessive lipid droplet accumulation in the pyloric caeca and liver, and reduced plasma cholesterol levels. Intestinal and hepatic gene expression profiling revealed an up-regulation of the expression of genes involved in lipid absorption and lipoprotein (LP) synthesis (apo, fatty acid transporters, microsomal TAG transfer protein, acyl-CoA cholesterol acyltransferase, choline kinase and choline-phosphate cytidylyltransferase A), cholesterol synthesis (3-hydroxy-3-methylglutaryl-CoA reductase) and associated transcription factors (sterol regulatory element-binding protein 2 and PPARγ). SA inclusion resulted in reduced body pools of cholesterol and bile salts. The hepatic gene expression of the rate-limiting enzyme in bile acid biosynthesis (cytochrome P450 7A1 (cyp7a1)) as well as the transcription factor liver X receptor and the bile acid transporter abcb11 (ATP-binding cassette B11) was down-regulated by SA inclusion. A significant interaction was observed between PM inclusion and SA inclusion for plasma cholesterol levels. In conclusion, gene expression profiling suggested that the capacity for LP assembly and cholesterol synthesis was up-regulated by PM exposure, probably as a compensatory mechanism for excessive lipid droplet accumulation and reduced plasma cholesterol levels. SA inclusion had hypocholesterolaemic effects on Atlantic salmon, accompanied by decreased bile salt metabolism.

Information

Type
Full Papers
Copyright
Copyright © The Authors 2013 
Figure 0

Table 1 Formulation of the experimental diets

Figure 1

Table 2 Primer pair sequences, efficiency, amplicon size and annealing temperature for the genes* used for real-time PCR

Figure 2

Fig. 1 Severity of steatosis of the pyloric (A) caeca and (B) liver of fish fed the experimental diets, representative for (a) absent (normal), (b) slight, (c) moderate and (d) marked. , Large vacuoles of TAG fat. (A colour version of this figure can be found online at http://www.journals.cambridge.org/bjn).

Figure 3

Fig. 2 Growth performance (A), concentrations of blood plasma cholesterol and bile salts (B) and concentrations of bile salts in digesta (C) of fish fed the experimental diets: fish meal (FM, ); fish meal with soya-saponin (FM-SA; ); plant meal (PM; ); plant meal with soya-saponin (PM-SA; ). Values are means, with standard errors represented by vertical bars. * Mean values were significantly different from those for plant meal inclusion (P< 0·05; two-way ANOVA). For plasma cholesterol, plasma bile salts and digesta bile salts, there was a significant effect for soya-saponin inclusion (P< 0·05; two-way ANOVA). For plasma cholesterol, there was a significant interaction between plant meal and soya-saponin inclusion (P< 0·05; two-way ANOVA). SGR, specific growth rate; PI, pyloric intestine; MI, mid-intestine; DI, distal intestine.

Figure 4

Table 3 Two-way ANOVA of the data for growth, cholesterol and bile salt levels, and gene expression of fish fed the experimental diets

Figure 5

Table 4 Severity of steatosis of the pyloric caeca and liver of fish fed the experimental diets*

Figure 6

Fig. 3 Pyloric caecal gene expression of monoacylglycerol acyltransferase 2-A (mgat2a), apoB, apoAI, apoAIV, microsomal TAG transfer protein (mtp), acyl-CoA cholesterol acyltransferase (acat), choline kinase (chk), choline-phosphate cytidylyltransferase 1A (pcyt1a), cluster of differentiation 36 (cd36), fatty acid transport protein (fatp), fatty acid-binding protein 2 isoforms (fabp2a1/fabp2b) and PPAR isoforms (pparα/pparγ). Values are means, with standard errors represented by vertical bars. * Mean values were significantly different from those for plant meal inclusion (P< 0·05; two-way ANOVA). For cd36, fatp, fabp2b and pparγ, there was a significant effect for soya-saponin inclusion (P< 0·05; two-way ANOVA). FM, Fish meal (); FM-SA, fish meal with soya-saponin (); PM, plant meal (); PM-SA, plant meal with soya-saponin (); MNE, mean normalised expression.

Figure 7

Fig. 4 Hepatic gene expression of 3-hydroxy-3-methylglutaryl-CoA reductase (hmgcr), sterol regulatory element-binding protein 2 (srebp2), cytochrome P450 7A1 (cyp7a1), ATP-binding cassette G5 and B11 (abcg5 and abcb11), liver X receptor (lxr), farnesoid X receptor (fxr), PPAR isoforms (pparα/pparγ), apoB, apoAI, microsomal TAG transfer protein (mtp), acyl-CoA cholesterol acyltransferase (acat), fatty acid transport protein (fatp) and cluster of differentiation 36 (cd36). Values are means, with standard errors represented by vertical bars. * Mean values were significantly different from those for plant meal inclusion (P< 0·05; two-way ANOVA). For cyp7a1, abcg5, lxr and abcb11, there was a significant effect for soya-saponin inclusion (P< 0·05; two-way ANOVA). FM, fish meal (); FM-SA, fish meal with soya-saponin (); PM, plant meal (); PM-SA, plant meal with soya-saponin (); MNE, mean normalised expression.

Figure 8

Fig. 5 Proposed molecular regulation of lipoprotein (LP) assembly, and cholesterol (CH) and bile acid (BA) metabolism based on data from the present study and previous studies in fish and mammalian species. In the intestinal lumen, products of lipid hydrolysis are solubilised in micelles (MI) and presented to the apical membrane of enterocytes. Fatty acids (FA) are transported from the intestinal lumen into the enterocytes by protein transporters including Cd36 (cluster of differentiation 36) and fatty acid transport protein (Fatp) or by protein-independent diffusion. Within the cytoplasm, FA are shuttled by fatty acid-binding protein 2 (Fabp2). Acyl-CoA cholesterol acyltransferase (Acat) and monoacylglycerolacyltransferase (Mgat) are located in the endoplasmic reticulum (ER) membrane, where they facilitate the esterification of CH and monoacylglycerols (MAG), respectively. These esterified products are assembled into proximal lipoproteins (PLP) with apoB in a microsomal TAG transfer protein (Mtp)-dependent manner. The PLP is merged with apoAIV to form a nascent lipoprotein (NLP) by core expansion. Choline kinase (Chk) and choline-phosphate cytidylyltransferase (Pcyt1a) are the committed and rate-limiting enzymes in the synthesis of phosphatidylcholine (PC) from choline (CL). PC is used in the formation of the polar lipid coat of NLP. Within the Golgi lumen, apoAI is attached to NLP to form a mature LP. The LP is released from the enterocyte to enter the circulatory system. LP are transported to the liver, in fish supposedly via the portal veins, and recognised by LP receptor-related proteins (LRP). In hepatocytes, the intestinal LP are disassembled and new LP, i.e. VLDL, are formed. apoB and Mtp participate in the formation of VLDL. apoAI is also secreted by the liver. CH and primary BA are the major constituents of bile that are synthesised in the liver and released into the biliary duct via the specific membrane transporters ATP-binding cassette G5 and B11 (Abcg5 and Abcb11), respectively. Both CH and BA are stored in the gall bladder and released into the intestine upon ingestion of feed. In the hepatocytes, sterol regulatory element-binding protein 2 (Srebp2) up-regulates the expression of genes involved in CH synthesis (3-hydroxy-3-methyl-glutaryl-CoA reductase (hmgcr)). Liver X receptor (Lxr) is activated by oxysterols, and it up-regulates the expression of genes involved in CH catabolism (cytochrome P4507A1 (cyp7a1)) and transport (abcg5). Farnesoid X receptor (Fxr) is activated by BA and controls intracellular BA levels by the regulation of Cyp7a1. PPAR isoforms (Ppar) are associated with the regulation of CH and BA metabolism, possibly by interaction with Srebp2. , Activation; , inhibition; , possible interaction.